Supernus Pharmaceuticals(SUPN) - 2024 Q4 - Earnings Call Transcript

Supernus Pharmaceuticals (SUPN) Q4 2024 Earnings Call February 26, 2025 02:53 AM ET Company Participants Peter Vozzo - Managing DirectorJack Khattar - CEO, President & DirectorTimothy Dec - Senior VP & CFOAndrew Tsai - SVPJack Padovano - Equity Research Associate - BioPharma Conference Call Participants Stacy Ku - AnalystDavid Amsellem - Sr. Research AnalystKristen Kluska - Managing Director, Biotechnology Equity Research Analyst Operator Good afternoon, and welcome to Supernus Pharmaceuticals Fourth Quarte ...